Keros Therapeutics, Inc.
KROS
$11.58
$0.110.96%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 559.93M | 530.68M | 405.86M | 442.44M | 331.15M |
| Total Receivables | 4.46M | 1.92M | 1.35M | 1.78M | 1.09M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.73M | 2.38M | 2.83M | 1.56M | 1.64M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 22.77M | 17.06M | 22.68M | 17.34M | 13.42M |
| Total Current Assets | 588.89M | 552.05M | 432.71M | 463.13M | 347.29M |
|
|
|||||
| Total Current Assets | 588.89M | 552.05M | 432.71M | 463.13M | 347.29M |
| Net Property, Plant & Equipment | 23.49M | 24.19M | 18.94M | 19.43M | 19.47M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.51M | 3.04M | 3.37M | 3.26M | 3.26M |
| Total Assets | 615.89M | 579.27M | 455.02M | 485.82M | 370.03M |
|
|
|||||
| Total Accounts Payable | 4.60M | 4.98M | 6.54M | 4.99M | 5.45M |
| Total Accrued Expenses | 20.45M | 21.82M | 13.15M | 11.83M | 17.25M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.98M | 1.86M | 1.10M | 1.05M | 1.01M |
| Total Finance Division Other Current Liabilities | 416.00K | 354.00K | 466.00K | 855.00K | 665.00K |
| Total Other Current Liabilities | 416.00K | 354.00K | 466.00K | 855.00K | 665.00K |
| Total Current Liabilities | 27.45M | 29.01M | 21.25M | 18.72M | 24.37M |
|
|
|||||
| Total Current Liabilities | 27.45M | 29.01M | 21.25M | 18.72M | 24.37M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 16.88M | 17.43M | 12.86M | 13.15M | 13.44M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 44.33M | 46.44M | 34.11M | 31.87M | 37.81M |
|
|
|||||
| Common Stock & APIC | 1.14B | 1.06B | 890.71M | 878.49M | 713.64M |
| Retained Earnings | -568.78M | -522.75M | -469.80M | -424.54M | -381.43M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 571.55M | 532.84M | 420.92M | 453.95M | 332.21M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 571.55M | 532.84M | 420.92M | 453.95M | 332.21M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 571.55M | 532.84M | 420.92M | 453.95M | 332.21M |
|
|
|||||
